Bicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company developing a novel class of precision-guided therapeutics (Bicycles®) for diseases that are underserved by existing therapeutics.
Address
CambridgeMassachusetts
United States